ASYS vs TECH · rev $101.2M vs P/E 65, rev $1.22B
Amtech Systems Inc (ASYS) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Amtech Systems Inc (ASYS) is a semiconductor equipment & materials company listed on US.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported ASYS revenue for 2024-09-30 was $101.2M. Net income was -$8.5M. Revenue was down 10.7% from 2023-09-30 to 2024-09-30. ASYS currently screens at market cap $64.1M.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
ASYS currently screens at market cap $64.1M. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the ASYS and TECH stock pages for the full models.
Not investment advice.